SABBY MANAGEMENT, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 7 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2018$2,137,000
-40.8%
650
+9.8%
0.47%
+1.7%
Q3 2018$3,609,000
+13.0%
592
-9.5%
0.46%
-6.3%
Q2 2018$3,193,000
-79.3%
654
-54.9%
0.49%
-46.4%
Q1 2018$15,408,000
+363.3%
1,450
+160.3%
0.92%
+203.6%
Q4 2017$3,326,000
+2363.7%
557
+406.4%
0.30%
+3687.5%
Q4 2016$135,000
-96.3%
110
-95.4%
0.01%
-93.2%
Q4 2014$3,689,000
+437.8%
2,380
+262.8%
0.12%
+160.0%
Q3 2013$686,0006560.04%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2018
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 325,000$19,812,0001.78%
SABBY MANAGEMENT, LLC 592$3,609,0000.46%
BOOTHBAY FUND MANAGEMENT, LLC 221$1,347,0000.13%
GROUP ONE TRADING, L.P. 118,300$7,212,0000.06%
SIMPLEX TRADING, LLC 253$1,542,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 15,000$914,0000.00%
View complete list of NEKTAR THERAPEUTICS shareholders